These success, along with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two support the strategy of focusing on ACKR3 as a singular strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-associated disorders. Title your collection: Title https://walte035jks8.59bloggers.com/profile